Vernakalant versus procainamide for rapid cardioversion of patients with acute atrial fibrillation (RAFF4): randomised clinical trial

Journal:

The BMJ

Published:

2025-11-11

DOI:

10.1136/bmj-2025-085632

Affiliations:

19

Authors:

27

Go to article

Institutions	Authors	Share
The Ottawa Hospital (TOH), Canada	12.000000 12.000000	0.44
Montreal Heart Institute, UdeM, Canada	2.000000	0.07
Dalhousie University, Canada	2.000000	0.07
Queen's University, Canada	2.000000	0.07
University of Ottawa Heart Institute, Canada	1.000000	0.04
Centre Intégré Universitaire de Santé et de Services Sociaux du Nord-de-l’Île-de-Montréal (CIUSSS du Nord-de-l’Île-de-Montréal), Canada	1.000000	0.04
Hôpital de l'Enfant-Jésus, UL, Canada	1.000000	0.04
University of Calgary (U of C), Canada	1.000000	0.04
CHU de Québec, UL, Canada	1.000000	0.04
University of Montreal (UdeM), Canada	1.000000	0.04
Quebec Heart and Lung Institute (IUCPQ), UL, Canada	1.000000	0.04
The University of British Columbia (UBC), Canada	0.500000	0.02
Vancouver Coastal Health Research Institute (VCHRI), Canada	0.500000	0.02
Centre intégré de santé et de services sociaux (CISSS) de Chaudière-Appalaches, Canada	0.500000	0.02
Laval University (UL), Canada	0.500000	0.02

Interested in Cardiovascular Medicine and Haematology?